John A. Hey

Chief Tech/Sci/R&D Officer at ALZHEON, INC.

64 year

Health Technology

Consumer Services

Profile

John A.
Hey is currently the Chief Scientific Officer at Alzheon, Inc. Prior to this, he was the Senior Director-Neurobiology at Schering-Plough Research Institute from 1988 to 2006.
He then served as the SVP-Discovery & Preclinical Drug Development at CoMentis, Inc. from 2006 to 2010, and as the Senior VP-Preclinical & Early Development at NormOxys, Inc. from 2010 to 2012.
Dr. Hey received his undergraduate degree from the University of Oklahoma.

John A. Hey active positions

Companies	Position	Start
ALZHEON, INC.	Chief Tech/Sci/R&D Officer	-

All active positions of John A. Hey

Former positions of John A. Hey

Companies	Position	End
NormOxys, Inc. NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA.	Corporate Officer/Principal	2011-12-31
CoMentis, Inc. CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA.	Corporate Officer/Principal	2009-12-31
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Corporate Officer/Principal	2005-12-31

See the detail of John A. Hey's experience

Training of John A. Hey

University of Oklahoma

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John A. Hey's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
NormOxys, Inc. NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA.	Health Technology
Alzheon, Inc. Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA.	Health Technology
CoMentis, Inc. CoMentis, Inc. Pharmaceuticals: MajorHealth Technology CoMentis, Inc. focuses on developing drugs to treat various central nervous system disorders. Its research and development spectrum include BACE inhibitors and modulators of the a7 nicotinic acetylcholine receptor (NAChR). The company was founded by John P. Cooke and Muralitharan Kengatharan in 2006 and is headquartered in South San Francisco, CA.	Health Technology
Schering-Plough Research Institute Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.	Health Technology

See company connections